<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table4" position="float"><label>Table 4.</label><caption><title>Mendelian randomization inverse variance weighted estimates for genetically mimicked effects of the anti-inflammatory anakinra raising IL-1Ra (effect size) (<xref ref-type="bibr" rid="bib75">Swerdlow et al., 2012</xref>) on testosterone (effect size) and ischemic heart disease and for genetically mimicked effects of tocilizumab raising serum IL-6r (ng/ml) (<xref ref-type="bibr" rid="bib48">Rafiq et al., 2007</xref>) on testosterone in men and women using the UK Biobank .</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th valign="top">Therapy</th><th valign="top">Target</th><th valign="top">Outcome</th><th valign="top"># SNPs</th><th valign="top">Measure</th><th valign="top">Estimate</th><th valign="top">95% CI</th><th valign="top">p-value</th></tr></thead><tbody><tr><td valign="top">Men</td><td valign="top">Anakinra</td><td valign="top">IL-1Ra</td><td valign="top">testosterone</td><td valign="top">2</td><td valign="top">beta</td><td valign="top">0.022</td><td valign="top">0.01 to 0.04</td><td valign="top">0.002</td></tr><tr><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top">IHD</td><td valign="top">2</td><td valign="top">OR</td><td valign="top">1.08</td><td valign="top">1.01 to 1.15</td><td valign="top">0.017</td></tr><tr><td valign="top"/><td valign="top">Tocilizumab</td><td valign="top">IL-6r</td><td valign="top">testosterone</td><td valign="top">1</td><td valign="top">beta</td><td valign="top">0.003</td><td valign="top">&#8722;0.06 to 0.13</td><td valign="top">0.96</td></tr><tr><td valign="top">Women</td><td valign="top">Anakinra</td><td valign="top">IL-1Ra</td><td valign="top">testosterone</td><td valign="top">2</td><td valign="top">beta</td><td valign="top">&#8722;0.01</td><td valign="top">&#8722;0.04 to 0.01</td><td valign="top">0.24</td></tr><tr><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top">IHD</td><td valign="top">2</td><td valign="top">OR</td><td valign="top">0.99</td><td valign="top">0.91 to 1.08</td><td valign="top">0.86</td></tr><tr><td valign="top"/><td valign="top">Tocilizumab</td><td valign="top">IL-6r</td><td valign="top">testosterone</td><td valign="top">1</td><td valign="top">beta</td><td valign="top">0.002</td><td valign="top">&#8722;0.02 to 0.02</td><td valign="top">0.84</td></tr></tbody></table><table-wrap-foot><fn><p>SNPs mimicking anakinra are rs6743376 and rs1542176.</p><p>The SNP mimicking tocilizumab is rs7529229.</p></fn><fn><p>An effect size of testosterone is approximately, 0.23 nmol/L in women (<xref ref-type="bibr" rid="bib24">Haring et al., 2012</xref>) and 3.1 nmol/L in men (<xref ref-type="bibr" rid="bib39">Mohr et al., 2005</xref>).</p></fn></table-wrap-foot></table-wrap>